Traumatic brain injury and circulating biomarkers: the CREACTIVE trial, an interview with Guido Bertolini

Written by Sharon Salt, Editor

Guido Bertolini is the head of the Laboratory of Clinical Epidemiology at the Mario Negri Institute (Milan, Italy). He is also a clinical epidemiologist and coordinator of the CREACTIVE study – a large network of ICUs across seven countries in Europe focused on treating traumatic brain injury (TBI) patients. In this interview, Guido speaks to us about the first results from the CREACTIVE trial, including the short- and long-term implications of this research. He also provides his opinion on where the field may be in 10 years’ time. You’ve presented a talk on circulating biomarkers for TBI prognostication, where you...

To view this content, please register now for access

It's completely free